News coverage about Cerner Corporation (NASDAQ:CERN) has trended somewhat positive this week, Accern Sentiment Analysis reports. The research firm identifies positive and negative news coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Cerner Corporation earned a coverage optimism score of 0.24 on Accern’s scale. Accern also gave news stories about the company an impact score of 45.711891506563 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

These are some of the media headlines that may have impacted Accern Sentiment’s scoring:

Shares of Cerner Corporation (NASDAQ CERN) traded up 0.84% during trading on Tuesday, hitting $63.44. The stock had a trading volume of 1,119,478 shares. The company has a market cap of $21.04 billion, a P/E ratio of 32.06 and a beta of 0.95. Cerner Corporation has a one year low of $47.01 and a one year high of $69.28. The stock’s 50-day moving average price is $64.81 and its 200-day moving average price is $61.36.

Cerner Corporation (NASDAQ:CERN) last announced its earnings results on Thursday, July 27th. The company reported $0.56 EPS for the quarter, missing the consensus estimate of $0.57 by $0.01. The company had revenue of $1.29 billion for the quarter, compared to analysts’ expectations of $1.30 billion. Cerner Corporation had a net margin of 13.47% and a return on equity of 18.18%. The business’s quarterly revenue was up 6.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.58 earnings per share. On average, equities research analysts forecast that Cerner Corporation will post $2.50 EPS for the current fiscal year.

Cerner Corporation announced that its Board of Directors has approved a stock repurchase plan on Thursday, May 25th that authorizes the company to buyback $500.00 million in outstanding shares. This buyback authorization authorizes the company to purchase up to 2.3% of its stock through open market purchases. Stock buyback plans are generally an indication that the company’s board believes its stock is undervalued.

CERN has been the topic of several research analyst reports. Cantor Fitzgerald restated a “buy” rating and issued a $77.00 price objective (up from $68.00) on shares of Cerner Corporation in a report on Monday, June 5th. BidaskClub upgraded shares of Cerner Corporation from a “buy” rating to a “strong-buy” rating in a report on Tuesday, June 27th. Hilliard Lyons lowered shares of Cerner Corporation from a “buy” rating to a “neutral” rating and boosted their price objective for the company from $62.00 to $68.00 in a report on Tuesday, May 2nd. Barclays PLC restated a “hold” rating and issued a $60.00 price objective on shares of Cerner Corporation in a report on Monday, May 1st. Finally, J P Morgan Chase & Co restated an “overweight” rating and issued a $72.00 price objective (up from $65.00) on shares of Cerner Corporation in a report on Tuesday, June 6th. One equities research analyst has rated the stock with a sell rating, sixteen have assigned a hold rating and seven have issued a buy rating to the company’s stock. Cerner Corporation has an average rating of “Hold” and a consensus target price of $65.79.

ILLEGAL ACTIVITY NOTICE: This report was first published by Watch List News and is owned by of Watch List News. If you are viewing this report on another website, it was illegally stolen and republished in violation of U.S. and international copyright and trademark laws. The legal version of this report can be accessed at

In related news, CFO Marc G. Naughton sold 60,000 shares of the firm’s stock in a transaction dated Tuesday, June 6th. The stock was sold at an average price of $68.63, for a total transaction of $4,117,800.00. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Linda M. Dillman sold 4,600 shares of the firm’s stock in a transaction dated Monday, May 22nd. The shares were sold at an average price of $64.69, for a total value of $297,574.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 248,913 shares of company stock worth $16,252,337. Company insiders own 13.20% of the company’s stock.

Cerner Corporation Company Profile

Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.

Insider Buying and Selling by Quarter for Cerner Corporation (NASDAQ:CERN)

Receive News & Ratings for Cerner Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.